Prevalence of ICU-Acquired Myopathy in Patients with Alcohol Use Disorders
Prevalence of ICU-Acquired Myopathy in Patients with Alcohol Use Disorders
批准号:
10400667
负责人:
Sarah E Jolley
金额:
$11.22万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-05-01 至 2023-04-30
关键词:
Acute respiratory failureAlcohol abuseAlcohol consumptionAlcoholsAmericanAwarenessBiological MarkersBiopsyCaringChronicCollaborationsCritical IllnessDataDevelopmentDiagnosisDiagnosticElectrophysiology (science)EnvironmentEvaluationExerciseFunctional disorderFutureGoalsHealthHistologicHospitalsImpairmentInjuryIntensive CareIntensive Care UnitsInterventionIntervention TrialInvestigationLongitudinal StudiesMeasurableMeasurementMechanical ventilationMentorsMethodsMicroRNAsMolecularMorbidity - disease rateMuscleMuscle functionMuscular AtrophyMyopathyOrganOutcomePatientsPhenotypePhysical FunctionPopulationPrevalenceRecoveryRegulationResearchResearch InfrastructureResearch MethodologyResearch PersonnelResearch TrainingRespiratory FailureRisk FactorsSeveritiesSkeletal MuscleSurvivorsTechniquesTestingTherapeutic InterventionTrainingTranslational ResearchUnemploymentUnited Statesalcohol exposurealcohol use disordercirculating microRNAcohortdiagnostic criteriadisease heterogeneitydisease prognosisexperiencefollow-upfunctional disabilityhealth care service utilizationmeetingsminimally invasivemortalitymuscle formmyogenesisneuromuscularnonhuman primatepatient orientedpreventrepairedrespiratoryresponseskillsspecific biomarkerssurvivorshipultrasound
中文摘要
摘要
英文摘要
ABSTRACT
Alcohol use is common in the United States with up to 7% of Americans meeting diagnostic criteria for
alcohol use disorder (AUD). AUD is a significant risk factor for poor health outcomes and up to 1.5 million
AUD patients require intensive care annually. However, little is known regarding the overall impact of AUD
on intensive care unit (ICU) survivorship. Muscle wasting is the most common organ manifestation of
alcohol abuse and contributes to respiratory compromise. Yet, no studies to date have investigated the
impact of muscle disease on outcomes from respiratory failure in AUD patients. Currently, the diagnosis of
neuromuscular dysfunction (NMD) relies on a combination of electrophysiology (EP) testing and muscle
biopsy, both of which are often impractical in routine ICU care. Recent data suggest that measurement of
muscle specific microRNAs (myomiRs) may accurately reflect ongoing myogenesis. We posit that specific
myomiRs might provide an easily measurable, specific biomarker for alcohol-related muscle injury that may
differentiate alcohol-related muscle disease and NMD in patients with acute respiratory failure (ARF). We
hypothesize that alcohol is an independent risk factor for NMD in respiratory failure patients and that
circulating myomiRs (c-myomiRs), miR-1, -133a/133b, -206, will accurately identify muscle injury in AUD
patients with ARF. To test this hypothesis, subjects will undergo serial EP testing and muscle ultrasound
(Aim 1) to identify prevalent alcohol-related muscle disease and incident NMD. Subjects will undergo serial
c-miRNA measurement (Aim 3) followed by a percutaneous muscle biopsy at day 7 of mechanical
ventilation to determine the concordance between muscle and circulating miRNA expression. Finally, this
cohort will be followed longitudinally (Aim 2) with functional testing and detailed alcohol assessment at
hospital discharge, 2 weeks and 6 months post-hospitalization to determine the long-term impact of alcohol-
related muscle disease on functional impairment. These assessments will provide the applicant with training
in 1) the pathophysiology of muscle injury and the regulation of muscle repair, 2) minimally invasive
techniques for assessing muscle mass and function, 3) molecular techniques for identifying muscle injury,
and 4) integrative approaches to the evaluation of AUD. This will advance the applicant towards her
expressed goal of becoming an independent investigator studying the long-term impacts of alcohol-related
muscle disease on critical illness.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1371/journal.ppat.1010359
发表时间:
2022-05
期刊:
PLoS pathogens
影响因子:
6.7
作者:
[]
通讯作者:
DOI:
10.1007/s00134-019-05593-2
发表时间:
2019-05
期刊:
INTENSIVE CARE MEDICINE
影响因子:
38.9
作者:
[Heyland, Daren K., van Zanten, Arthur R. H., Grau-Carmona, Teodoro, Evans, David, Beishuizen, Albertus, Schouten, Jeroen, Hoiting, Oscar, Luisa Bordeje, Maria, Krell, Kenneth, Klein, David J., Gonzalez, Jesus, Perez, Aitor, Brown, Randy, James, Joyce, Harris, M. Scott, Jolley, Sarah, Raines, Ronald, Servia-Goixart, Lluis, Perez-Quesada, Sonia, Ignacio Herrero-Meseguer, Jose, Calvo-Herranz, Enrique, Lorencio, Carol, Peredes, Amparo, Carlos Yebenes-Reyes, Juan, Angel Garcia-Martinez, Miguel, Cervera, Manuel, Franscisco Fernadez-Ortega, Juan, Fernandez-Gonzalez, Inmaculada, van Zanten, Arthur, Stelfox, Tom, Posadas, Juan]
通讯作者:
Posadas, Juan
DOI:
10.1097/cce.0000000000000658
发表时间:
2022-03
期刊:
Critical care explorations
影响因子:
--
作者:
[Danesh V, Boehm LM, Eaton TL, Arroliga AC, Mayer KP, Kesler SR, Bakhru RN, Baram M, Bellinghausen AL, Biehl M, Dangayach NS, Goldstein NM, Hoehn KS, Islam M, Jagpal S, Johnson AB, Jolley SE, Kloos JA, Mahoney EJ, Maley JH, Martin SF, McSparron JI, Mery M, Saft H, Santhosh L, Schwab K, Villalba D, Sevin CM, Montgomery AA]
通讯作者:
Montgomery AA
DOI:
10.1016/j.jtcvs.2022.12.013
发表时间:
2024-05
期刊:
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
影响因子:
6
作者:
[Cain, Michael T., Taylor, Lauren J., Colborn, Kathryn, Teman, Nicholas R., Hoffman, Jordan, Mayer, Kirby P., Etchill, Eric W., Sevin, Carla M., Jaishankar, Sruthi, Ramanan, Raj, Enfield, Kyle, Zwischenberger, Joseph B., Jolley, Sarah E., Rove, Jessica Y.]
通讯作者:
Rove, Jessica Y.
Novel Statewide Response to Post-COVID Care Delivery
-
批准号:10866088
-
项目类别:
-
资助金额:$99.59万
-
财政年份:2023
-
负责人:Sarah E Jolley
-
依托单位:
Prevalence of ICU-Acquired Myopathy in Patients with Alcohol Use Disorders
-
批准号:10153600
-
项目类别:
-
资助金额:$11.22万
-
财政年份:2018
-
负责人:Sarah E Jolley
-
依托单位:
海外基金